Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen lowered shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Friday morning. A number of other equities research analysts also recently weighed in on BDTX. Wedbush reaffirmed an “outperform” rating and set a $11.00 price objective […]
Wall Street Zen lowered shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Friday morning. A number of other equities research analysts also recently weighed in on BDTX. Wedbush reaffirmed an “outperform” rating and set a $11.00 price objective […]
